Alzheimer's Association Commends United Kingdom's Approval of Leqembi, But Condemns Decision to Deny NHS Access
- Written by PR Newswire
![]() |
CHICAGO, Aug. 23, 2024 /PRNewswire/ -- The Alzheimer's Association welcomes today's decision by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA) to approve Leqembi® (lecanemab) for the treatment of Alzheimer's disease. However, while celebrating this milestone — the first Alzheimer's disease modifying...















